Department of
Senior investigator Simon Haroutounian, PhD, chief of clinical research at the Washington University Pain Center alongside other researchers at Washington University School of Medicine have found that many people who tested positive for the coronavirus in the early months of the pandemic also experienced peripheral neuropathy during and following their bouts with COVID-19.
The Department of Anesthesiology at Washington University School of Medicine in St. Louis ranked #2 nationwide among anesthesiology departments in funding from the National Institutes of Health (NIH).
Global researchers created a wireless network utilizing implantable devices and equipment integrated with IoT technology, enabling neuroscience experiments that can virtually study the brains of animals.
Led by Jose Moron-Concepcion, PhD, the findings (published online Oct. 18 in the journal Nature Neuroscience) could lead to treatments targeting the emotion-related aspects of pain.
The National Institute of Mental Health (NIMH) has awarded Washington University School of Medicine in St. Louis a five-year, $12.2 million grant to create a center aimed at advancing research into neurosteroids as treatments for depression and other psychiatric disorders.
In a recent study published in Nature Neuroscience, Dr. Ream Al-Hasani and colleagues have identified a new role for a GABA projection in reward processing which could lead to new treatments for addiction and depression.
Clinicians and researchers at Washington University School of Medicine in St. Louis have received a four-year, $6.2 million grant from the National Institute of Mental Health to launch a center designed to help improve mental health in surgery patients, particularly older surgery patients. The center will conduct studies to identify and treat depression and anxiety in surgical patients. This new center is the first NIH-funded center of its kind in the United States.
The ASOS-2 project was a response to the findings in ASOS-1, that African surgical patients are twice as likely to die in the hospital after surgery than the international average. The project aimed to shift the limited existing resources available for postoperative surveillance towards those patients at higher risk of developing postoperative complications.
Funded by a $33 million grant from the Patient-Centered Outcomes Research Institute (PCORI), a new study led by Michael Avidan, MBBCh, of Washington University School of Medicine in St. Louis and Sachin Kheterpal, MD, of the University of Michigan, will compare intravenous propofol to inhaled anesthetic drugs to determine which of the common anesthetic drugs offers better patient recovery experiences and improved clinical outcomes.
The Daniel X. Freedman Award is given for outstanding achievements in basic research by a Brain & Behavior Research Foundation Young Investigator and honors outstanding scientists working to advance the prevention, diagnosis and treatment of psychiatric illness.